Monthly Archives: March 2010

Don't miss the April 1 online presentation on treatment as prevention

By on .

Can ARV treatment be used to prevent HIV infection?  What are the implications?  How far along is the science? Mark your calendar to hear an online presentation and discussion on treatment as prevention, Thursday, April 1 at 10am EDT. You can ask questions via the web as it is taking place, and you can also […]

XDR Becoming More Resistant: "We Will Run Out of Letters Soon"

By on .

Last week, the Global Center released a new issue brief on drug-resistant TB to mark World TB Day. Included in the brief was this interview with Dr. Sarita Shah, who recently presented new research showing that strains of extensively drug-resistant TB (XDR-TB) in Tugela Ferry, South Africa, are becoming more resistant. Tugela Ferry is ground […]

White House Leadership Needed to Make Bill Gates’ Vaccine Vision a Reality

By on .

This is a guest blog by Holly Wong, vice president of public policy for the International AIDS Vaccine Initiative. Testifying recently before the Senate Foreign Relations Committee on the President’s Global Health Initiative (GHI), Bill Gates highlighted the critical role health technologies play in economic development. He also reiterated a call, first made in January […]

Doing TB Diagnosis With Shopkeepers and Bicycles? Not a Sustainable Strategy

By on .

There were plenty of frightening statistics and unsettling trends highlighted at today’s World TB Day briefing on Capitol Hill. But one photo captured the true scope of the problem in scaling up diagnosis and treatment of the global TB epidemic. Celine Gounder, MD, an IDSA member and TB/HIV specialist at Johns Hopkins University, described a […]

World TB Day Briefing Will Shine New Light on Epidemic

By on .

Tomorrow is World TB Day—and the halfway point for the Global Plan to Stop TB. What better time to learn about the latest TB research and the most innovative approaches to combating combat this ancient deadly epidemic? Those items will be on the agenda tomorrow, along with data about the virulent threat of drug-resistant TB, […]

Senate Panel May Weigh In On Uganda's Anti-Gay Bill

By on .

On Thursday, a powerful Senate panel is expected to ramp up pressure on Uganda’s leaders to kill an anti-gay bill that would criminalize homosexuality and is now pending in that country’s Parliament.    At issue is Uganda’s Anti-Homosexuality Bill, which would impose life imprisonment or a death sentence for same-gender consensual sex and threatens prison time for […]

WHO Report on Drug-Resistant TB Paints Unsettling Picture

By on .

What is more worrisome when it comes to drug-resistant TB: What we do know about the epidemic? Or what we don’t know? The latest World Health Organization report on the epidemic provides plenty of both—some grim facts and some disconcerting question marks.  Take these nuggets: *A shocking 41 percent of countries cannot provide reliable data […]

Maternal Health and HIV/AIDS in CSIS Report

By on .

This posting is by Rabita Aziz, Program Associate at the IDSA/HIVMA Global Center The new report by the Center for Strategic and International Studies (CSIS) Commission on Smart Global Health Policy  calls for the U.S. to double contributions to better maternal and child health, to $2 billion a year.  Such investments should be focused on […]

Reactions to the New CSIS Report on "Smart Global Health Policy"

By on .

The Center for Strategic and International Studies yesterday unveiled  a new “must-read” report for global health advocates, “Smart Global Health Policy.” While a panel at the Congressionally-chartered Institute of Medicine, made up primarily of scientists, issued recommendations on US global health policy last year, the CSIS panel is the first to involve high-level business leaders […]

Public and Private Sector Partners Help to Jump Start Development of New TB Drug Combinations

By on .

This post is by Global Center Director Christine Lubinski. The excitement in the room was palatable today as FDA Commissioner Margaret Hamburg joined representatives from the Global Alliance for TB Drug Development, the Bill & Melinda Gates Foundation, the Treatment Action Campaign, and representatives from the pharmaceutical industry to announce a new collaboration to accelerate […]